Consolidated Balance Sheets (Unaudited) - USD ($)	Feb. 28, 2025	Nov. 30, 2024
Current Assets
Cash	$ 16,672	$ 25,348
Prepaid expenses	46,231	56,786
Total Current Assets	62,903	82,134
Cash and investments held in trust account	7,227,936	31,665,013
Total Assets	7,290,839	31,747,147
Current liabilities
Accounts payable and accrued liabilities	1,633,415	1,551,553
Extension loan	2,817,736	2,766,371
Working capital loan	1,129,000	1,047,000
Total Current Liabilities	5,580,151	5,364,924
Deferred underwriter commission	4,025,000	4,025,000
Total Liabilities	9,605,151	9,389,924
Commitments and Contingencies
Class A ordinary shares subject to possible redemption574,543 and 2,568,240 shares (at $12.58 and $12.33 per share) as of February 28, 2025 and November 30, 2024, respectively	7,227,936	31,665,013
Shareholders’ Deficit
Preference Shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of February 28, 2025 and November 30, 2024
Additional paid-in capital
Accumulated deficit	(9,542,589)	(9,308,131)
Total Shareholders’ Deficit	(9,542,248)	(9,307,790)
Total Liabilities and Shareholders’ Deficit	7,290,839	31,747,147
Common Class A [Member]
Shareholders’ Deficit
Common stock, value	341	341
Common Class B [Member]
Shareholders’ Deficit
Common stock, value